Rhuematology is constantly evolving and we’re here to help you, not just keep up to date, but to equio you to be the pioneers behind the innovations that improve results for your patients. We’re also making sure rhuematology is represented in government policy.
We run registers of patients receiving biological treatments, these collect data on patient safety and drug efficacy.
This is dummy text lorum ipsum dolor sit amet labore magna aliqua member benefits are to help you.
This is dummy text lorum ipsum dolor sit amet labore magna aliqua member benefits are to help you.
This is dummy text lorum ipsum dolor sit amet labore magna aliqua member benefits are to help you.
Read report >This is dummy text lorum ipsum dolor sit amet labore magna aliqua member benefits are to help you.
The Best Practice Tariff (BPT) for early inflammatory rheumatoid arthritis (EIA) came into use in April 2013, supported by the BSR, Arthritis Research UK and the Department of Health.
BSR recommends that rhuematology departments should participate in peer review on a 5-yearly basis as a means to facilitate improvements in clinical services and to ensure basic core standards are met.
This is dummy text lorum ipsum dolor sit amet labore magna aliqua member benefits are to help you. This is dummy text lorum ipsum dolor sit amet labore magna aliqua member benefits are to help you.
Get involved >